Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 3
Abstract
Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and PSMA-directed radioligand therapy (RLT) with Lutetium-177 (Lu-177) PSMA is promising systemic modality, which involves the delivery of targeted radiation therapy in the form of β-particles to sites of tumour tissue. Although, Lu-177 PSMA RLT has been recently introduced for castration-resistant metastatic prostate cancer (CRMPC), has continuously increasing interest and use in many centers. Therapy is well tolerated with relatively few side effects and has a positive effect on overall survival and quality of life. The purpose of this guideline is to assist nuclear medicine specialists in evaluating and managing patients with RCMPC for whom RLT using Lu-177 PSMA as an “unproven intervention in clinical practice”, in accordance with the best currently available knowledge.
Authors and Affiliations
İlknur Ak Sivrikoz, Gülin Uçmak, Gamze Kaya Çapa, Emre Demirci, Nalan Alan Selçuk, Cüneyt Türkmen, Umut Elboğa, Levent Kabasakal
Keywords
Related Articles
- EP ID EP691580
- DOI 10.4274/nts.galenos.2020.0031
- Views 97
- Downloads 0
Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as...
Good Radiopharmacy Practice (GRP): Personnel and Training
Radiopharmaceuticals are medical products that are used for diagnosis and/or treatment in humans and containing one or more radionuclides (radioisotopes). The shelf life and expiry period of the radiopharmaceutical prepa...
Non-ultrasonographic and Non-radioiodine Imaging Techniques in Thyroid Cancer
Ultrasonography is the most commonly used and most effective imaging modality in thyroid cancer imaging. It is the most successful method for evaluating primary tumor and local disease. I-131 scintigraphy is also a usefu...
The Use of F-18-FDG PET/CT in Renal and Bladder Tumors
Clinical imaging has been the cornerstone to guide patient management and therapy strategies for oncology patients. In the last decades, the use of fluorodeoxyglucose positron emission tomography/computed tomography (PET...
Options and Auxiliary Surgical Techniques in Residual or Recurrent Nodal Disease in Differentiated Thyroid Cancers
Despite their very good prognosis, residual or recurrent nodal disease can be seen in approximately 30% of patients in differentiated thyroid cancers (DTC). Nodal disease is most common in the neck and it can be treated...